Hospital groups, specialty clinic chains, diagnostic centre operators, and primary care networks are all expanding into new geographies – driven by rising healthcare demand, government healthcare investment, and the commercial opportunity in markets where private healthcare quality is limited. GreyRadius helps healthcare providers validate patient demand, navigate regulatory and licensing requirements, identify partnership and acquisition opportunities, and raise capital – grounded in primary research with patients, clinicians, regulators, and hospital administrators.
Why now? Southeast Asia and South Asia are experiencing a healthcare infrastructure deficit that is attracting international hospital groups, specialty clinic chains, and medical equipment distributors. The Gulf's healthcare system expansion – driven by national health strategies in Saudi Arabia and UAE – is creating both greenfield and joint venture opportunities for international healthcare providers. The investment windows tied to these national programmes are open now.
Private healthcare spending in Southeast Asia is growing at 12% annually – driven by rising middle-class incomes, inadequate public healthcare capacity, and increasing chronic disease burden.
Medical tourism is a $100B+ global market – with Thailand, India, Malaysia, and Turkey as established destinations, and the Gulf, Vietnam, and Indonesia as emerging medical tourism markets.
Telemedicine integration is becoming a standard component of private hospital strategy – providers that offer hybrid in-person and digital care are achieving higher patient retention and broader geographic reach.
Specialty care – oncology, cardiology, orthopaedics, and fertility – is growing faster than general healthcare in emerging markets as middle-class consumers seek specialist care for complex conditions.
If you recognise your situation below, we can help.
Patient demand validation
You need to validate that sufficient patient demand exists in your target market for your clinical speciality and price point before committing to facility investment.
Regulatory licensing pathway
You need to understand hospital licensing requirements, medical staff registration, equipment import approvals, and health ministry requirements in your target market.
Location and facility assessment
You need to evaluate potential facility locations, catchment area demographics, and competition density to identify the optimal market entry point.
Joint venture and acquisition target identification
You need to identify potential local healthcare partners, acquisition targets, or joint venture opportunities in your target market.
Raising capital for healthcare expansion
You are raising investment for a hospital or clinic chain expansion and need a pitch book grounded in patient demand data and clinical market sizing.
Medical tourism programme strategy
You are evaluating international patient attraction and need a GTM plan covering referral partnerships, payer relationships, and patient acquisition channels.
Every engagement is grounded in primary research and delivers a measurable outcome.
Validate patient demand and market opportunity for healthcare provider expansion. Covers patient surveys, clinician and administrator interviews, competitive mapping, and a Go/Defer/Kill recommendation.
Learn more →Full financial and operational feasibility for hospital and clinic investments. Covers patient volume modelling, staffing cost, facility capex, revenue per patient, and bankable financial projections.
Learn more →End-to-end market entry for healthcare providers. Regulatory pathway, facility location assessment, JV partner identification, and first-admitted-patient or first-clinic-opening milestone.
Learn more →Embedded GTM team for healthcare groups. Payer and insurance network development, referral physician outreach, and first-revenue milestone tracking.
Learn more →Investor-ready pitch books for healthcare expansions. Patient-demand-validated market sizing, clinical quality narrative, and investor identification across healthcare PE and family offices.
Learn more →AI use-case prioritisation in hospital operations – from diagnostic AI and clinical decision support to patient flow optimisation and revenue cycle automation.
Learn more →80% of our insight comes from first-party interviews with buyers, competitors, and regulators – not secondary data that everyone else has.
Our AI layer compresses research timelines by 60% and surfaces pattern-matching from 200+ prior mandates – so you get faster, deeper answers.
We measure success by first contracts signed, capital raised, and markets entered – not deliverables produced. Every mandate has a milestone.
200+
Projects delivered
100+
SaaS & tech clients
80%
Primary research-led
4
Countries / offices
Not sure where to start?
Answer 3 questions about your business stage and market entry goal. Takes 90 seconds. We will tell you which GreyRadius service applies and what a first engagement would look like.
Free. No commitment. No sales pitch in the first call.
100+
mandates delivered since 2017
30+
primary expert interviews per engagement
4
geographies – India, Gulf, Southeast Asia, Africa
8+
years of emerging market engagements
What clients say
“
GreyRadius gave us the market intelligence we needed to enter GCC with confidence – validated KOL contacts, distributor shortlists, and a regulatory timeline that was 30% faster than our original estimate.
“
The buyer research was the turning point. We'd spent 12 months building pipeline in the wrong markets. GreyRadius told us where the real demand was, validated by actual decision-makers – not polite interest.
Medical Devices · Market Entry
Medical Devices · GTM
Medical Devices · Assessment
All three. We work with hospital groups on market entry and feasibility, specialty clinics on GTM and market entry, and diagnostic centres on market entry and fundraising.
Southeast Asia, South Asia, the Gulf, and Africa – markets with significant private healthcare demand and government health investment.
Typically 8–12 weeks given the complexity of regulatory licensing research and patient demand assessment.
Yes. JV partner identification and initial commercial discussions are part of our market entry execution service for healthcare companies.
GreyRadius research notes, market entry signals, and sector briefs – delivered weekly. No fluff.
Not sure which engagement fits? Take our free 2-minute diagnostic →
When you get in touch
Discovery call
30 minutes. We learn your situation. You learn how we work.
Within 48 hours
Engagement scoped
Scope, research plan, and outcomes agreed before work begins.
Week 1
Primary research
30+ expert interviews. Buyers, regulators, distributors, competitors.
Weeks 2–5
Recommendation delivered
Go/Defer/Kill with the primary evidence your board needs to act.
Week 6–8
Choose the option that matches where you are right now. No commitment required at any stage.
Starting out
Run our free diagnostic
Answer 3 questions about your situation. Get a personalised service recommendation in 90 seconds.
Start the diagnostic →Evaluating options
See how we structure an engagement
Download our one-page overview – scope, timeline, deliverable format, and what primary research produces.
Request the overview →Ready to start
Book a 30-minute call
Speak with a GreyRadius partner. No pitch – we will tell you what primary research in your sector and market would actually reveal.
Book the call →Typical first response within 4 business hours.
